Journal of Microbiology

The Microbiological Society of Korea (한국미생물학회)
권호 표지

High Prevalence of the China 1 Strain of Epstein-Barr Virus in Korea as Determined by Sequence Polymorphisms in the Carboxy-Terminal Tail of LMP1

  • Cho, Sung-Gyu (Division of Biosciences and Bioinformatics and Institute of Biosciences and Biotechnology, Myongji University) ;
  • Lee, Won-Keun (Division of Biosciences and Bioinformatics and Institute of Biosciences and Biotechnology, Myongji University)
  • Published : 2003.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

The Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMPI) exhibits considerable sequence heterogeneity among EBV isolates. Seven distinct EBV strains have been defined based on sequence polymorphisms in the LMPI gene, which are designated China 1, China 2, China 3, Alaskan, Mediterranean, NC, and the B95-8 strains. In this study, we analyzed a 30-bp deletion and sequence variations in the carboxy-terminal region of the LMPl gene in 12 EBV isolates from spontaneous lym-phoblastoid cell lines derived from individuals with non-EBV associated cancers in Korea. Eleven of the 12 isolates showed a 30-bp deletion spanning LMPI amino acids 342 to 353, suggesting a high prevalence of the LMPI 30-bp deletion variant among EBV isolates in Korea. In addition, all 12 isolates had a 15-bp common deletion in the 33-bp repeat region and multiple base-pair changes relative to the prototype B95-8 EBV strain along with variations in the number of the 33-bp repeats. The bp changes at positions 168746, 168694, 168687, 168395, 168357, 168355, 168631, 168320, 168308, 168295, and 168225 were highly conserved among the isolates. Comparative analysis of sequence change patterns in the LMPI carboxy-terminal coding region identified nine 30-bp deletion variants as China 1, two deletion variants as a possible interstrain between the Alaskan and China 1 strains, and a single undeleted variant as a possible variant of the Alaskan strain. These results suggest the predominance of the China 1 EBV strain in the Korean population.

Keywords

References

  1. Oncogene v.13 Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas Bhatia,K.;A.Raj;M.I.Guitierrez;J.G.Judde;G.Spangler;H.Venkatesh;I.T.Magrath
  2. J. Microbiol. v.36 Sequence analysis of the latent membrane protein 1 genes of Epstein-Barr virus isolates in Korea Cho,S.;S.G.Cho;Y.S.Shim;W.K.Lee
  3. J. Microbiol. Biotechnol. v.10 Analysis of genetic polymorphisms of Epstein-Barr virus isolates from cancer patients and healthy carriers Cho,S.G.;W.K.Lee
  4. Mol. Cell. Biol. v.16 Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation Devergne,O.;E.Hatzivassiliou;K.M.Izumi;K.M.Kaye;M.F.Kleijnen;E.Kieff;G.Mosialos
  5. Virology v.261 Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains Edwards,R.H.;F.Seillier- Moiseiwitsch;N.Raab- Traub https://doi.org/10.1006/viro.1999.9855
  6. J. Biol. Chem. v.274 Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production Eliopoulos,A.G.;N.J.Gallagher;S.M.Blake;C.W.Dawson;L.S.Young https://doi.org/10.1074/jbc.274.23.16085
  7. Oncogene v.16 Activation of the cJun Nterminal kinase (JNK) pathway by the Epstein- Barr virusencoded latent membrane protein 1 (LMP1) Eliopoulos,A.G.;L.S.Young https://doi.org/10.1038/sj.onc.1201694
  8. Semin. Cancer Biol. v.11 LMP1 structure and signal transduction. Eliopoulos,A.G.;L.S.Young https://doi.org/10.1006/scbi.2001.0410
  9. J. Gen. Virol. v.76 The role of repetitive DNA sequences in the size variation of Epstein- Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR analysis Falk,K.;J.W.Gratama;M.Rowe;J.Z.Zou;F.Khanim;L.S.Young;M.A.Oosterveer;I.Ernberg https://doi.org/10.1099/0022-1317-76-4-779
  10. EMBO J. v.18 Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins Gires,O.;F.Kohlhuber;E.Kilger;M.Baumann;A.Kieser;C.Kaiser;R.Zeidler;B.Scheffer;M.Ueffing;W.Hammerschmidt https://doi.org/10.1093/emboj/18.11.3064
  11. J. Virol. v.76 The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines Higuchi,M.;E.Kieff;K.M.Izumi https://doi.org/10.1128/JVI.76.1.455-459.2002
  12. J. Gen. Virol. v.72 Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma Hu,L.F.;E.R.Zabarovsky;F.Chen;S.L.Cao;I.Ernberg;G.Klein;G.Winberg https://doi.org/10.1099/0022-1317-72-10-2399
  13. Oncogene v.10 The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain Huen,D.S.;S.A.Henderson;D.Croom- Carter;M.Rowe
  14. J. Virol. v.73 The residues between the two transformation effector sites of Epstein- Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation Izumi,K.M.;E.D.Cahir;McFarland;E.A.Riley;D.Rizzo;Y.Chen;E.Kieff
  15. Mol. Cell. Biol. v.19 The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation Izumi,K.M.;E.D.Cahir McFarland;A.T.Ting;E.A.Riley;B.Seed;E.D.Kieff
  16. Proc. Natl. Acad. Sci. USA v.90 Epstein-Barr virus latent membrane protein 1 is essential for B- lymphocyte growth transformation Kaye,K.M.;K.M.Izumi;E.Kieff https://doi.org/10.1073/pnas.90.19.9150
  17. Proc. Natl. Acad. Sci. USA v.95 Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice Kulwichit,W.;R.H.Edwards;E.M.Davenport;J.F.Baskar;B.Godfrey;N.Raab Traub https://doi.org/10.1073/pnas.95.20.11963
  18. J. Biol. Chem. v.267 The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B Laherty,C.D.;H.M. Hu;A.W.Opipari;F.Wang;V.M.Dixit
  19. Vitro Cell. Dev. Biol.: Animal v.34 Characterization of B-lymphoblastoid cell lines established from Korean cancer patients Lee,W.K.;S.M.Kim;Y.S.Shim;S.G.Cho;S.H.Park;C.W.Kim;J.G.Park https://doi.org/10.1007/s11626-998-0090-1
  20. J. Gen. Virol. v.75 Sequence variation in the Epstein-Barr virus latent membrane protein 1 Miller,W.E.;R.H.Edwards;D.M.walling;N.Raab-Traub https://doi.org/10.1099/0022-1317-75-10-2729
  21. J. Virol. v.71 Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF- kappaB activation Miller,W.E.;G.Mosialos;E.Kieff;N.Raab-Traub
  22. Virology v.192 Strain variation in Epstein-Barr virus immediate early genes Packham,G.;M.Brimmell;D.Cook;A.J.Sinclair;P.J.Farrell https://doi.org/10.1006/viro.1993.1070
  23. J. Virol. v.64 Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes Sample,J.;L.Young;B.Martin;T.Chatman;E.Kieff;A.Rickinson
  24. Blood v.90 Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates Sandvej,K.;J.W.Gratama;M.Munch;X.G.Zhou;R.L.Bolhuis;B.S.Andresen;N.Gregersen;S.Hamilton-Dutoit
  25. Mol. Cells v.8 Sequence variation of EBNA2 of Epstein-Barr virus isolates from Korea Shim,Y.S.;C.W.Kim;W.K.Lee
  26. Int. J. Cancer v.76 Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China Sung,N.S.;R.H.Edwards;F.Seillier-Moiseiwitsch;A.G.Perkins;Y.Zeng;N.Raab Traub https://doi.org/10.1002/(SICI)1097-0215(19980413)76:2<207::AID-IJC7>3.0.CO;2-0
  27. Cell v.43 An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells Wang,D.;D.Liebowitz;E.Kieff https://doi.org/10.1016/0092-8674(85)90256-9
  28. J. Virol. v.64 Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23 Wang,F.;C.Gregory;C.Sample;M.Rowe;D.Liebowitz;R.Murray;A.Rickinson;E.Kieff